Abbott delivers a strong quarter outpacing the Indian Pharma market growth YOY but sequential growth being flattish concerns rise for the company | Abbott India Q3FY22 Result Analysis
Abbott delivers a strong quarter outpacing the Indian Pharma market growth YOY but sequential growth being flattish concerns rise for the company | Abbott India Q3FY22 Result Analysis
Abbott delivers a strong quarter outpacing the Indian Pharma market growth YOY but sequential growth being flattish concerns rise for the company | Abbott India Q3FY22 Result Analysis
Published on 11 February 2022 .Views 15.Comments 0
Download
